Date published: 2025-10-31

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr630 Inhibitors

Olfr630, a member of the olfactory receptor family, plays a crucial role in the intricate process of olfactory signal transduction. Positioned within the nasal epithelium, Olfr630 functions as a G-protein-coupled receptor (GPCR), pivotal for detecting and transducing diverse odorant signals. Olfactory receptors, including Olfr630, are integral to the initial steps of olfaction, allowing organisms to perceive and distinguish a vast array of smells in their environment. The activation of Olfr630 initiates a signaling cascade within olfactory sensory neurons, ultimately leading to the transmission of olfactory information to higher brain centers for interpretation.

Inhibition of Olfr630 involves a sophisticated interplay of chemical compounds targeting key cellular pathways associated with its function. These inhibitors act either directly on Olfr630 or indirectly by modulating crucial signaling pathways. For instance, histone deacetylase inhibitors, such as Suberoylanilide Hydroxamic Acid, impact Olfr630 gene expression by modifying the epigenetic landscape. Other inhibitors, like those targeting p38 MAP kinase or PI3K-Akt pathway, indirectly influence Olfr630 by disrupting intracellular signaling, thereby altering the receptor's responsiveness to odorants. Additionally, inhibitors affecting NF-κB signaling may regulate Olfr630 expression through modulation of inflammatory responses. The diverse mechanisms of inhibition underscore the intricate nature of olfactory receptor regulation and highlight the multifaceted approaches employed to modulate Olfr630 function within the olfactory system.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SP2509

1423715-09-6sc-492604
5 mg
$284.00
(0)

SP2509, an inhibitor of histone demethylase LSD1, influences Olfr630 indirectly by modulating the epigenetic regulation of gene expression. It may impact the accessibility of Olfr630's gene, altering its expression and responsiveness to odorants.

Doramapimod

285983-48-4sc-300502
sc-300502A
sc-300502B
25 mg
50 mg
100 mg
$149.00
$281.00
$459.00
2
(1)

Doramapimod (BIRB 796) is a selective p38 MAP kinase inhibitor. Its action on the p38 pathway indirectly affects Olfr630, potentially influencing downstream cellular responses associated with olfactory signal transduction.